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The reversible redox conversion of nitrite and nitric oxide (dNO) in a physiological setting is now widely
accepted. Nitrite has long been identiﬁed as a stable intermediate of dNO oxidation but several lines of
evidence support the reduction of nitrite to nitric oxide in vivo. In the gut, this notion implies that nitrate
from dietary sources fuels the longstanding production of nitrite in the oral cavity followed by univalent
reduction to dNO in the stomach. Once formed, dNO boosts a network of reactions, including the
production of higher nitrogen oxides that may have a physiological impact via the post-translational
modiﬁcation of proteins and lipids. Dietary compounds, such as polyphenols, and different prandial
states (secreting speciﬁc gastric mediators) modulate the outcome of these reactions. The gut has
unusual characteristics that modulate nitrite and dNO redox interplay: (1) wide range of pH (neutral vs
acidic) and oxygen tension (c.a. 70 Torr in the stomach and nearly anoxic in the colon), (2) variable lumen
content and (3) highly developed enteric nervous system (sensitive to dNO and dietary compounds, such
as glutamate). The redox interplay of nitrite and dNO might also participate in the regulation of brain
homeostasis upon neuronal glutamatergic stimulation in a process facilitated by ascorbate and a
localized and transient decrease of oxygen tension. In a way reminiscent of that occurring in the
stomach, a nitrite/dNO/ascorbate redox interplay in the brain at glutamatergic synapses, contributing to
local dNO increase, may impact on dNO-mediated process.
We here discuss the implications of the redox conversion of nitrite to dNO in the gut, how nitrite-
derived dNO may signal from the digestive to the central nervous system, inﬂuencing brain function, as
well as a putative ascorbate-driven nitrite/NO pathway occurring in the brain.
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Nitric oxide (dNO), an ubiquitous free radical produced via a
highly regulated enzymatic process in vivo, modulates a wide range
of signaling pathways in virtually all body organs and systems [1].
Physiological mechanisms, such as the regulation of vascular tone,
host response as well as learning and memory formation are tightly
regulated by this diffusible free radical [2]. Upon its synthesis via NO
synthases (NOS), dNO may embark in reactions with biomolecular
targets, being ultimately neutralized into the supposedly inert
oxidation products nitrite and nitrate [3]. Both anions have been
disregarded as inert products devoid of physiological relevance but
recently it was demonstrated that nitrate and nitrite might be
stepwisely reduced back to dNO in vivo.
The so-called nitrate-nitrite-NO pathway, by opposition to the
classical L-arginine-NOS pathway, implies that nitrate and nitrite
fuel the production of dNO, a process particularly evident in the
gastrointestinal compartment for nitrate from dietary sources
originates nitrite in the oral cavity and dNO in the stomach [4].
The gut is therefore a primary site for the production of signiﬁ-
cantly high dNO concentrations [5,6]. The nitrite reduction to dNO
has also been described in other compartments/tissues under
hypoxic conditions, a condition in which several hemeproteins
(e.g., myoglobin, hemoglobin, xanthine oxidase, among others)
acquire a nitrite-reductase activity, ensuring dNO bioavailability
under oxygen deprivation [7]. Taken together, these observations
suggest a reciprocal relationship between nitrite and dNO during
redox signaling mechanisms.Nitrite and nitric oxide in the gut: luminal warfare or welfare?
The production of dNO from nitrate obligates the intermediary
formation of nitrite [4]. Nitrate, obtained from the diet or endo-
genously produced upon dNO oxidation, is mixed with saliva in the
oral cavity and travels along the gut being absorbed in the small1
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Fig. 1. EPR analysis of the reaction between caffeic acid or ascorbic acid with nitrite. (A)
obtained under ﬂow conditions upon mixing 2 mM of the compounds with 4 mM of nitri
before being pumped to the EPR cavity. (B) In vivo dNO production in the stomach of h
beverages indicated. Reproduced from Gago B, Lundberg JO, Barbosa RM, Laranjinha J. Re
Med 43(9):1233–42; 2007 and Rocha BS, Gago B, Barbosa RM, Laranjinha J. Dietary polyp
relaxation. Toxicology 265(1–2):41–8; 2009 with permission from Elsevier.intestine. The salivary glands then recover c.a. 20% of circulating
nitrate and secrete it into the oral cavity where it is reduced to
nitrite by the local microﬂora and mixed with saliva, thus estab-
lishing the enterosalivar circulation of nitrate [8,9].
Under the acidic conditions of the gastric juice, nitrite is
protonated to nitrous acid (HNO2), which then decomposes into
different nitrogen oxides, depending on the redox microenviron-
ment and gastric content [10,11]. Under normal fasting conditions,
HNO2 yields dNO and nitrogen dioxide radical (dNO2) which may
trigger signaling cascades by direct interaction with hemeproteins,
such as soluble guanylate clyclase in the case of dNO, or by
oxidizing and nitrating proteins and lipids in the case of dNO2
[1,12]. Nitric oxide and dNO2 may also combine to produce
dinitrogen trioxide (N2O3) [13], a nitrosating agent. Dinitrogen
trioxide reacts with gastric chloride, phosphate and bicarbonate
anions to form nitrosyl compounds that nitrosate secondary
amines, a process that has been claimed to support a deleterious
effect of dietary nitrite [14]. However, N2O3 hydrolysis to nitrite
and HNO2 is kinetically favored rather than N-nitrosation [14]. Of
note, nitrite has also been shown to induce S-nitrosation within
the gastric compartment, suggesting that this posttranslational
modiﬁcation may also be considered as part as nitrite redox
signaling [15]. Finally, two dNO2 molecules may also combine to
generate dinitrogen tetraoxide (N2O4) which under aqueous solu-
tions yields both nitrate and nitrite [16].
However, this scenario is expected to change after a meal.
During a postprandial period, ascorbic acid is secreted together
with gastric juice into the lumen and, upon reaction with nitrite, is
oxidized to ascorbyl radical whereas nitrite is univalently reduced
to dNO (Fig. 1A) [6,17]. Consequently, in the presence of endogen-
ous reducing agents, the network of reactions is shifted towards
dNO production [6,18,19]. This raised the question as to whether
dietary products could modulate the intricate dynamics of nitrite
and dNO in the acidic gastric lumen. Here, we highlight three
mechanisms by which nitrite signals in vivo through redox
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ealthy volunteers following consumption of lettuce and the dietary products and
d wine-dependent reduction of nitrite to nitric oxide in the stomach. Free Radic Biol
henols generate nitric oxide from nitrite in the stomach and induce smooth muscle
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The paradigm deﬁning polyphenols as global antioxidants has
nowadays been largely discredited for many reasons reviewed
elsewhere [20]. Yet, more than 8000 different polyphenols are
provided by the human diet and their health beneﬁts are well
established from the epidemiologic viewpoint, suggesting that
other mechanisms operate in vivo [21]. One of them relies
precisely on the nitrite-NO interplay in the gastric lumen. Foods
(and beverages, including the red wine) rich in polyphenols, in a
way reminiscent of ascorbate, have been shown to boost dNO
production from nitrite at acidic pH in the human stomach
[6,18,19]. Upon the consumption of lettuce (as a rich source of
nitrite) and of red wine, apples or black tea (as rich sources of
polyphenols) the intragastric dNO levels in humans rise by about
three orders of magnitude (Fig. 1B) [19]. Mechanistically, we have
shown that dietary nitrite is univalently reduced to dNO while the
polyphenol is oxidized to the corresponding o-semiquinone radi-
cal (Fig. 1A) [6]. As a result, two radicals are produced: dNO and the
phenoxyl radical. They can both combine to produce nitroso
derivatives or, due to the high oxygen tension in the stomach
(≈70 Torr [22]), dNO may be oxidized to dNO2 which, in turn, can
combine with the phenoxyl radicals yielding nitrated phenols [23].
Of note, the trimolecular reaction of dNO with oxygen, considered
to be too slow to be pertinent in vivo (k¼8106 M−1s−1) [24],
acquires relevance in the gastric compartment as the steady state
concentrations of both reagents are unusually high.
Although thermodynamically feasible [25], the mechanistic
details of nitrite reduction to dNO at the expenses of polyphenols
in the gastric environment still need further exploration. Overall, it
is now important to recognize that the interaction of nitrite with
polyphenols in the gastric lumen produces dNO, which diffuses
toward deep regions of the gastric mucosa [26,27], participating in
distinct physiological mechanisms such as smooth muscle relaxa-
tion [19], regulation of mucosal blood ﬂow and mucus thickness
[28,29] and also in the eradication of pathogens such as Helico-
bacter pylori [30].
Protein nitrosation
Wine has been identiﬁed as one of the polyphenol-containing
dietary sources that promote dNO production from nitrite in the
stomach (See Fig. 1B). Along with polyphenols, ethanol is a major
component of wine that can interact with nitrite under gastric
conditions [31]. The reaction of aliphatic alcohols, with nitrite-
derived reactive nitrogen species, such as HNO2 and N2O3 may
lead to the formation of alkyl nitrites of the corresponding
alcohols via O-nitrosation [32]. This family of organic nitrites are
known for their potent vasodilator activity [31]. Along these lines
we have demonstrated that, under acidic gastric conditions, ethyl
nitrite is formed in micromolar concentrations from the reaction
of red wine or distilled alcoholic drinks with nitrite at concentra-
tions that can be easily found physiologically [31]. Of note, ethyl
nitrite is as a potent nitrosating agent [33] and may indirectly
mediate dNO effects, as supported by relaxation experiments with
blood vessels and gastric strips [31].
Several chemical groups other than alcohols can be nitrosated
as a result of the nitrite chemistry in the stomach, namely
aromatic compounds, amines and thiols, yielding C-, N-, S- nitroso
species [34,35] along with heme moieties that produce heme-
nitrosyls (heme-nitrosylation) [36,37]. A further level in the
complex chemistry that may take place in the gastric compart-
ment is added by the observation that different physiological/
pathophysiological conditions may redirect the gastric chemistry
such as, for instance, an achlorhydric stomach, where the neutral
pH facilitates the formation of N-nitroso compounds (reviewed in[38]). The biological signiﬁcance of many of these modiﬁcations
remains obscure but S-nitrosation has received particular atten-
tion. The posttranslational modiﬁcation of a critical cysteine
residue in a protein by S-nitrosation can be relevant on the
regulation of protein function [39] and has been implicated in
controlling oxygen delivery to tissues, modulating the function or
activity of transcription factors, enzymes, membrane receptors and
ion channels [37]. Mechanistically, S-nitrosation may occur
between dNO and a thiol group, if a thyil radical is formed in the
cysteine residue [40] or, more importantly, by the action nitrogen
oxides (formally addition of a nitrosonium equivalent, NO+), such
as N2O3 formed, for instance, by the reaction of dNO with oxygen
[41]. It may be also considered that two different thiols can
undergo a fast transnitrosation reaction, which may explain in
part the high liability of S-nitrosothiols [42,43].
The stomach is a proper environment for protein S-nitrosation
for diet, saliva, gastric secretions (containing glutathione) and
mucus glycoproteins (cysteine-rich mucins) constitute potential
targets for S-nitrosation [28]. Considering the perfect timing
(nitrite consumption) and place for mucins nitrosation, we have
tried to elucidate the effects of the nitrite rich chemistry on the
mucus layer from a physiological and pathophysiological point a
view. A nitrosation pattern in the mucus proteins was found and,
moreover, can be modulated with diet components and endogen-
ous reductants (unpublished observations). It is tempting to
speculate that several dNO-like effects of nitrite described in the
stomach, such as stimulation of the mucosal blood ﬂow and mucus
generation, might proceed via intermediate formation of S-
nitrosothiols which can act as stable carriers of dNO. Finally, it
must be added that many of the compounds formed in the gastric
lumen from acidiﬁed nitrite are fairly stable and readily absorbed
which suggests systemic effects [4].
Protein and lipid nitration
In the gastric lumen, due to the low pH (c.a. 2 under fasting)
and unusually high nitrite concentrations (1–2 mM upon a nitrate
load [44]), nitrite triggers a complex network of chemical reactions
yielding oxidizing and nitrating agents. Different nitrite-
dependent nitrating pathways have been pointed out but dNO2
seems to be the main intermediate in most of them [45,46]. In the
stomach, two important sources of dNO2 may be forwarded: dNO
autoxidation and peroxynitrous acid (ONOOH) formation. As
aforementioned, the high concentrations of dNO and oxygen
achieved in the gastric lumen afford physiological signiﬁcance to
an apparently irrelevant reaction in vivo (dNO autoxidation). In
addition, dNO and superoxide radical (O2d−) combine at near limit
diffusion rate (k¼6.7109 M−1s−1) to produce ONOOH [47]. At
physiological pH, ONOOH exists in equilibrium with peroxynitrite
anion (ONOO−) (pKa¼6.8) but in the acidic gastric juice ONOOH is
the predominant form [48]. Peroxynitrous acid undergoes homo-
lytic cleavage to produce dNO2 and hydroxyl radical (dOH) [49]. To
this pathway aids the high carbon dioxide (CO2) tension in the
headspace and bicarbonate in the gastric juice that via the
production of nitrosoperoxycarbonate (ONOOCOO) drives the
formation of not only dNO2 but also carbonate radical (CO3d−),
which is an oxidant stronger than dNO2 [50,51]. This facilitates the
univalent oxidation or tyrosine to tyrosil radical (tyr-Od) (the ﬁrst
step of protein tyrosine nitration) and further radical combination
of tyr-Od and dNO2 (k¼3.0109 M−1s−1) [51].
Given this complex web of reactions, it is likely that dietary
nitrite activates oxidative signaling pathways in the stomach
trough protein posttranslational modiﬁcations. Accordingly, we
have observed nitrite-dependent protein (tyrosine) nitration
in vivo in the stomach [46]. We have observed that pepsin, a
gastric protease involved in the breakdown of dietary and mucosal
C. Pereira et al. / Redox Biology 1 (2013) 276–284 279proteins, is nitrated by both inorganic nitrite and human saliva
upon a nitrate load [52]. Pepsin nitration is inhibited by urate,
pointing to dNO2 as the nitrating agent arising from nitrite.
Moreover, this posttranslational modiﬁcation is associated with a
decrease of the proteolytic activity of the enzyme. These results
strongly support the hypothesis of nitrite, from dietary sources, to
signal through nitration reactions with functional and physiologi-
cal implications.
In addition to endogenous protein nitration, dietary com-
pounds may also be targeted for nitrite-dependent nitration,
notoriously dietary lipids, which have already been described to
go through structural modiﬁcations upon exposure to acidiﬁed
nitrite in vitro [53]. Therefore, lipid nitration afforded by gastric
nitrite is a hypothesis that requires further investigation [46].
Taken together, these considerations support the concept that
at acidic pH, protein and lipid nitration may constitute a yet poorly
characterized pathway accounting for nitrite signaling in vivo [46].Redox signaling by nitrite and nitric oxide from gut mucosa
and beyond
Once formed in the acidic gastric lumen, and in addition to
reactions with radicals, nitrogen oxides or macromolecules, dNO
diffuses towards the gastric mucosa [26,27], hence triggering
physiological responses. It increases mucus thickness (diets sup-
plemented with nitrate have been shown to increase MUC6
expression, [54]), enhances mucosal blood ﬂow (likely by binding
to endothelial guanylate clyclase in vascular smooth muscle cells)
and induces smooth muscle relaxation, inﬂuencing gastric empty-
ing rates (reviewed in [10]). There is a vast collection of biochem-
ical reactions in which dNO participates [11] that go beyond the
scope of this review but we would like to emphasize that dNO can
be also oxidized to nitrite and nitrate, contributing to a pool of
these anions in vivo [55]. However, the documented increase of
plasma and tissue nitrate and nitrite upon a nitrate load [56]
supports a dietary contribution to the in vivo pool of those anions
via, for instance, the enterosalivary recirculation.
In tissues, nitrite may trigger distinct signaling pathways, either
via dNO production or in a dNO-independent manner. An inter-
esting example of the later is myeloperoxidase (MPO), that can use
nitrite as a substrate to produce oxidizing (compound I and II) and
nitrating (dNO2) agents [57]. This reaction is of particular interest
throughout the gut mucosa due to the continuous recruitment of
polymorphonuclear cells that express this peroxidase as part of
their antimicrobial arsenal [58]. Therefore, nitrite may be expected
to trigger protein or lipid nitration reactions (at pH 7.4) through
MPO activation.
Below, we will brieﬂy address some of nitrite-dependent
signaling pathways.
Mitochondrial nitric oxide-nitrite cycle
Nitric oxide is known to regulate mitochondrial function
through mechanisms that include mitochondrial biogenesis [59],
reactive oxygen species production [60], cytochrome c release [61]
and inhibition of mitochondrial Complex I (NADH-ubiquinone
oxireductase) and Complex IV (cytochrome c oxidase, CcOX) [62].
CcOX, in turn, is endowed with a nitrite-reductase activity [63,64]
as well with a nitric oxide oxidase activity, particularly under
conditions of low electron ﬂux and in the presence of oxygen
(reviewed in [65]), indicating that the enzyme contributes to
nitrite physiological levels. In connection with these observations
it is interesting to note that recently, nitrite was shown to regulate
mitochondrial biogenesis in a dNO- and soluble guanylate cyclase-
independent manner [66].Complex I can be inhibited by dNO via S-nitrosation after a long
exposure to high dNO concentrations [67] and crucially depends
on the structural conformation of the enzyme which, in turn,
depends on the availability of oxygen and NADH. Under hypoxic
conditions, Complex I undergoes a transition between the active
form and the de-activated form, exposing a critical cysteine
residue that when S-nitrosated fully inhibits the enzyme [68,69].
Apparently, during re-oxygenation, the inhibited S-nitrosated
Complex I has a fundamental contribution for cell protection,
preventing the accumulation of reducing equivalents and ROS
(reactive oxygen species) production [70]. Regarding the inhibition
of complex IV (CcOX) by dNO and related species, two mechanisms
have generated consensus [71,72]. A ﬁrst reaction pathway
involves the formation of a NO-bound (nitrosyl) enzyme in the
ferrous heme a3 center and a second one produces nitrite-bound
CcOX on the ferric heme a3 center. Both pathways lead to the
reversible inhibition of the enzyme, and CcOX can restore its
activity via dissociation of both, dNO, the process being slow and
light-sensitive, and nitrite, the process being more rapid and light-
sensitive. Sarti and co-workers, showed that both mechanisms can
occur. Under conditions of low electron ﬂux and high oxygen
concentration, the ‘nitrite’ uncompetitive inhibition pathway pre-
vails, whereas the electron ﬂux is increased, and the oxygen
concentration reduced, the oxygen-competitive ‘nitrosyl’ pathway
tends to take over [71,72]. Recent evidences in favor of a nitrite
reductase activity of CcOX [73] under acidic conditions and low
oxygen tension, producing dNO, support that such a nitrite-
reductase activity plays a role in hypoxic cell signaling.
Taken together, the reaction of mitochondrial complexes I and
IV with dNO may trigger physiological or pathological events
[67,74] and it is of note that dNO bioavailability is intimately
related to the oxygen tension for conditions in which oxygen
decreases in tissues below normoxic conditions, the activity of
NOSs to produce dNO is progressively slowed. However, the fact
that the anoxic environment promotes tissue acidiﬁcation, favour-
ing the reduction of nitrite to dNO, highlights the importance of
the tissue/cell distribution of nitrite concerning the dNO chemistry
[4,75].
Hypoxic signaling
The nitrite-dependent redox signaling under low oxygen ten-
sion is largely dependent on its reduction to dNO by several
enzymes that acquire nitrite-reductase activity under these cir-
cumstances (for a recent review see [7]).Hemoglobin and myoglobin
Several enzymes ensure a nitrite-reductase activity along the
oxygen gradient but deoxygenated hemoglobin (plasma) and
myoglobin (tissues) are of foremost importance. Although at
different rates, both proteins may participate in the production
dNO by the same mechanism [76]. Nitrite interacts with the heme
group of deoxyhemoglobin [deoxyHb(Fe2+)], producing dNO and
methemoglobin [metHb(Fe3+)] [77,78] at rates that increase when
the protein conformation is changing from the R-to-T state (from
oxy to deoxy), being maximized when hemoglobin is 50% satu-
rated with oxygen [79]. It has been described that dNO hence
formed in the erythrocyte may originate N2O3 via its combination
with dNO2 which is present as a ferrous nitrogen dioxide
[dNO2(Fe2+)] in equilibrium with [NO2−(Fe3+)] [80]. The functional
signiﬁcance of this reaction is that N2O3 is much more stable than
dNO in the heme environment and therefore can escape the
erythrocyte and may then transduce dNO signal in the vessel or
endothelial compartment via, for instance, its ability to nitrosate
thiols [80]. Likewise, deoxymyoglobin acts as a nitrite reductase,
C. Pereira et al. / Redox Biology 1 (2013) 276–284280reducing nitrite to dNO faster than deoxyhemoglobin due to its
lower heme redox potential. This mechanism underlies some of
the mitochondrial effects of nitrite, as myoglobin:nitrite-derived
dNO, being produced in proximity to mitochondria, inhibits CcOX
and regulates mitochondrial respiration [81]. Such an effect on
oxygen bioavailability has been shown to positively impact in the
performance of healthy volunteers under submaximal exercise
upon dietary supplementation with nitrate [82]. In the heart,
under hypoxic conditions, dNO production via deoxymyoglobin
reduction of nitrite, downregulates the cardiac energy status,
oxygen consumption and tissue contractility [83], highlighting
the homeostatic effects of nitrite under particularly disfavored
conditions.
Xanthine oxidase (XO)
Besides the catabolism of purines and pyrimidines, XO is also
able to reduce oxygen to O2d− and hydrogen peroxide (H2O2).
However, it can also reduce nitrite to dNO at the molybdenum site
under hypoxic conditions in the presence of NADH as electron
donor [84]. The reaction is obviously affected by the tissue levels of
the enzyme but, additionally, its activity is critically controlled by
nitrite that, given the high value of Km (km¼2.5 mM), acts as the
limiting substrate [7]. Therefore, since the Km for nitrite exceed the
typical levels on nitrite by two orders of magnitude, it is likely that
only when nitrite levels rise above basal (such as when the gastric
mucosa is exposed to intense dNO ﬂuxes upon a nitrate load) this
reaction may acquire physiological relevance. Alternatively, under
ischemic conditions, when the pH drops and nitrite is converted
into HNO2, dNO production by this pathway is favored [7] and has
been suggested to protect against myocardial infarction [85].
Interestingly, for 70 mM oxygen, XO can univalently reduce both,
oxygen to O2d− and nitrite to dNO, and further considering that
both radicals can combine to produce ONOO− under normoxic
physiological conditions [86] one may envisage that nitrite may
also be implicated in ONOO− biological impact. Peroxynitrite is a
short-lived oxidant implicated in a wide range of diseases [87] and
therefore nitrite can be regarded as a Janus-faced molecule
because depending on the local microenvironment (e.g., oxygen
levels) it can activate protective pathways against ischemia or
trigger the formation of deleterious oxidants.
The enteric nervous system
Gastrointestinal mucosa houses submucosal and myenteric
plexuses that integrate gut and nervous functions, bridging the
enteric and central nervous systems [88]. Diet composition mod-
ulates not only gastrointestinal homeostasis but also the gut-brain
signaling through diverse mechanisms. For instance, there is an
operative amino acid sensing system within the gastric mucosa that
recognizes dietary glutamate [89]. Albeit being the major excita-
tory neurotransmitter in the central nervous system, this amino
acid also modulates important gut functions such as secretion,
motility and metabolism [90] via mechanisms that include the
generation of dNO and serotonin [91]. Given the high steady state
concentrations of dNO achieved in the gastric lumen and mucosa
upon nitrite reduction, glutamate-dependent pathways in the
gastrointestinal tract are likely to be modulated by dietary nitrate.Nitrite and nitric oxide in the central nervous system
Presley et al. have shown that a high nitrate diet increases the
blood ﬂow in speciﬁc brain areas in older subjects [92], introdu-
cing the notion that nitrate available from the diet may impact on
brain homeostasis. However, the mechanistic details that bridge
dietary nitrate and brain function remain largely elusive. Asaforementioned, upon a nitrate load there is an increase of both
nitrate and nitrite concentration in blood and tissues, but how
(and if) is nitrite converted into dNO in the brain and what is the
impact in brain functions such as cognition and memory formation
remains to be elucidated.
Given the critical role of dNO in the brain, a particular challen-
ging question is whether one can identify a brain selective or
favored mechanism that might affect the redox conversion
between nitrite and dNO and, thereby dNO-mediated process.
When considering the extremely high concentration of ascorbate
in neurons and the occurrence of glutamate:ascorbate exchangers
it is tempting to speculate that ascorbate might, under conditions
of excitatory stimuli, participate in nitrite-dependent dNO produc-
tion in the brain. Before addressing this hypothesis we will brieﬂy
review biochemical and physiological features of dNO in the brain.Basic tenets of nitric oxide in the brain: production, actions,
diffusion and inactivation
Upon neuronal activation, dNO production in the brain is
related to glutamatergic activity, involving the activation of iono-
tropic glutamate receptors (iGluR), particularly NMDA subtype,
and the consequent inﬂux of Ca2+ that activates neuronal isoform
of NOS (nNOS), thus promoting the conversion of L-arginine to L-
citrulline and dNO, in an oxygen dependent way [93,94]. Following
its production, dNO, among other targets, may activate soluble
guanylate cyclase, [95–98], triggering physiological responses that
are tissue and cell speciﬁc and include neuronal excitability,
synaptic plasticity, modulation of neurotransmitter release, learn-
ing and memory processes and neurovascular coupling [93,98–
100].
It is of note that dNO rapidly diffuses in the brain across cell
membranes with a coefﬁcient of 2. 210−5 cm2/s [101], interact-
ing with multiple targets, especially heme and other iron proteins
at relatively fast reactions (in the case of myo and hemoglobin rate
constants are of the order of 107 M−1 s−1) [102]. In the absence of
speciﬁc interaction with receptors, dNO actions are dependent on
its spatiotemporal proﬁle which, in turn, is dependent on the
balance between its synthesis and inactivation. Regarding the
latter process, on basis of selective microelectrodes stereotaxically
inserted in the rat brain in vivo [103–107], we have recently shown
that dNO has a half life of 0.64 s in rat cortex [101] and that
scavenging by erythrocytes represents the major inactivaction
pathway in the brain.Where nitric oxide and nitrite come together
Nitric oxide synthesized by the neuronal isoform of NOS
(nNOS) can not only regulate oxygen availability in tissues (via
mitochondrial actions described above) but also bridges neuronal
activity with local changes of blood ﬂow in the microcirculation of
the brain, a process known as neurovascular coupling [108]. Under
hypoxia, it is expectable that the activity of NOS (and, in particular
nNOS) is highly attenuated and, consequently, we would expect
that the decreased production of dNO translates into subsequent
impairment of blood ﬂow and compromised vasodilation. How-
ever, apparently, NOS inactivation during hypoxia does not block
vasodilation [109]. This observation adds to several others, includ-
ing the viability of mice lacking all three isoforms of NOS [110], to
suggest the occurrence of alternative and/or complementary path-
ways to ensure that tissues get the needed amount of dNO,
regardless of the functional state of the enzymes usually involved
in its synthesis. In this scenario, the possibility that dietary nitrite/
nitrate may contribute to basal levels of dNO signaling emerges as
100nM
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interaction becomes particularly relevant in maintaining the
balance between dNO production, oxygen consumption and neu-
rovascular coupling in the brain. Nitrite has shown to increase
blood ﬂow preferentially in hypoxic conditions, allowing blood
ﬂow to increase precisely where it is needed most [111–120]. This
shift from the classical view of nitrite as a simple by product of
dNO oxidation to a molecule with physiological impact, as dis-
cussed ahead, is associated with redox mechanisms leading to dNO
formation when enzymatic production is somehow compromised.
Based on preliminary data and on the rationale discussed ahead
we will propose a critical role for ascorbate in dNO biochemistry in
the brain via the univalent reduction of nitrite.20 µM   250 µM
Fig. 2. Nitric oxide production from a mixture of ascorbate and nitrite as a function
of pH. The reaction vessel was supplemented with 250 mM of ascorbate and 20 mM
of nitrite at a pH of 7.4. The vessel was coupled to an amiNOs sensor (selective for
dNO measurements) and to a pH meter. Current was allowed to stabilize. Then, pH
was slowly acidiﬁed until it reached the value of 6.51 (a value that can be reached
in vivo under hypoxic conditions). At this pH value, current increased indicating
that dNO was being produced. Maximum concentration of dNO obtained in these
conditions was 118 nM.Nitric oxide/ nitrite/ ascorbate cycle in the brain
Ascorbate is a powerful reducing agent highly concentrated in
the brain, both in the extracellular ﬂuid and cells, namely neurons
and astrocytes. Ascorbate is present at even higher concentrations
in areas such as the hippocampus where dNO has been shown to
play critical roles in learning and memory processes [121–123].
Ascorbate release from neuronal cells to the extracellular ﬂuid
occurs in connection with glutamatergic activity, and a putative
glutamate/ascorbate heteroexchange mechanism has been pro-
posed to regulate this ﬂow outwards the cells following stimula-
tion [124]. However, other reports failed to ﬁnd a direct correlation
between glutamatergic uptake and ascorbate release [125,126].
Nitric oxide undergoes oxidation to nitrite and this amount
adds to nitrite received from the diet, yielding a reservoir in the
extracellular ﬂuid. As discussed before, the reduction of nitrite
promoted by univalent reductants such as dietary polyphenols and
ascorbate is now well established in the gastric environment
where both reagents (nitrite and ascorbate) achieve optimal
conditions (low pH, high concentration) for the reduction of nitrite
to dNO occur.
Years ago, Millar elegantly described an alternative mechanism
for dNO production in the brain completely independent of
enzymatic control, involving the reduction of nitrite to dNO by
ascorbate released from neurons during increased neuronal activ-
ity [109]. In this regard, it is of note the millimolar range of
ascorbate concentration in neurons and also that ascorbate, which
is released following neuronal activity, could contribute to convert
nitrite to dNO, thus promoting beneﬁcial vasodilator actions on
blood vessels in the brain in the absence of an enzymatic and
oxygen requiring process, namely the NOS-catalyzing process. This
would be particularly important in hypoxia, because (a) the low of
oxygen compromises NOS activity and (b) during hypoxia, local pH
may drop to values near 6.4 [127] and, as depicted in Fig. 2, when
ascorbate and nitrite are in solution and pH drops from 7.4 to
values near 6.5 dNO production occurs.
However, considering that under glutamatergic stimulus local
oxygen drops to a very low tension, reaching a “hypoxia like”
transient status, it can be hypothesized that during this time
period pH will drop sufﬁciently to promote nitrite reduction to
dNO by the ascorbate hence released during the stimulation. In
agreement with this hypothesis preliminary experiments have
shown a temporal correlation between dNO and ascorbate
dynamics upon glutamate stimulation of rat hippocampus in vivo
(unpublished data), suggesting that ascorbate is contributing to
dNO signals upon glutamatergic stimulation.
The basal nitrite concentration in the extracellular space of
hippocampus is not accurately known and is likely to vary as a
function of the redox environment but on basis of a microdyalisis
approach in connection with a chemiluminescence measurement
of nitrite-derived nitric oxide a range between 50 and 400nanomolar was routinely found in male Wistar rats found [128].
On the other hand, nitrite concentration in the cerebrospinal ﬂuid
(of humans and rats), was reported to be circa 1 microM [129,130].
Under these conditions, the increase of dNO and ascorbate con-
centration in the extracellular space concurrently with a drop on
the local pH (since oxygen concentration also drops) might set the
conditions for nitrite reduction to dNO. The physiological outcome
is that nitrite/dNO/ascorbate redox interplay could contribute to
dNO-mediated processes such as the neurovascular coupling and
the subsequent blood ﬂow increase.
In summary, the redox couple nitrite:dNO in the brain might
acquire relevance under physiological conditions in which the
stimulation of glutamatergic terminals sets the environment and
facilitates the chemical conditions for nitrite univalent reduction
to dNO by ascorbate in a way reminiscent of what occurs in the
stomach. The notion of nitrite as dNO reservoir acquires a parti-
cular interest in the brain because dNO production is achieved
under physiological process, without the need to propose hypoxic
or ischemic conditions for dNO production. However, although
challenging, the hypothesis of the nitrite/dNO/ascorbate redox
interplay with functional consequences in the brain still needs to
be robustly substantiated.Acknowledgments
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